• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探索皂苷作为基于脂质纳米颗粒的mRNA疫苗佐剂的潜力。

Exploring the potential of saponins as adjuvants in lipid-nanoparticle-based mRNA vaccines.

作者信息

Eygeris Yulia, Jozic Antony, Henderson Michael I, Nelson Dylan, Sahay Gaurav

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, Oregon State University, Portland OR 97201, USA.

Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, OR 97239, USA.

出版信息

Mol Ther Methods Clin Dev. 2025 May 21;33(2):101495. doi: 10.1016/j.omtm.2025.101495. eCollection 2025 Jun 12.

DOI:10.1016/j.omtm.2025.101495
PMID:40525124
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12169741/
Abstract

Saponins are a class of phytocompounds known for their amphiphilic properties. Here, we have evaluated incorporation of 40 saponins into a model lipid nanoparticle (LNP) formulation and evaluated their performance and . We reasoned that the surfactant activity of saponins could be beneficial in the context of cell and gene therapy due to the disruption of the intracellular membranes. We established formulation methodology to incorporate saponins into LNPs and measured their endosomal disruption and transfection efficiency with DNA barcode and mRNA cargoes. We identified two saponins-quillaic acid and macranthoidin B-that increase the LNP transfection efficiency and endosomal disruption. Saponin formulations demonstrated cargo-dependent activation of the innate immune system, as measured by the cell-based assays of interferon regulatory factor (IRF) and NF-κB pathway activation. Quillaic acid LNPs resulted in higher titers of anti-OVA IgG2a in the vaccination studies compared to a "naive" LNP control, which suggests a more Th1-biased immunopathology of these vaccines. As Th2-biased vaccines can trigger an allergic response, an mRNA vaccine with a balanced Th1/Th2 response is more favorable for translation into the clinic. Overall, quillaic acid may serve as an adjuvant for mRNA vaccines and potentially decrease the risk of vaccine-associated adverse events.

摘要

皂苷是一类以两亲性特性而闻名的植物化合物。在此,我们评估了40种皂苷掺入模型脂质纳米颗粒(LNP)制剂中的情况,并评估了它们的性能。我们推断,由于皂苷具有破坏细胞内膜的作用,其表面活性剂活性在细胞和基因治疗方面可能是有益的。我们建立了将皂苷掺入LNPs的制剂方法,并使用DNA条形码和mRNA货物测量了它们的内体破坏和转染效率。我们鉴定出两种皂苷——齐墩果酸和大花紫薇素B——它们可提高LNP的转染效率和内体破坏能力。通过基于细胞的干扰素调节因子(IRF)和NF-κB途径激活检测发现,皂苷制剂表现出对先天免疫系统的货物依赖性激活。在疫苗接种研究中,与“未处理的”LNP对照相比,齐墩果酸LNP产生了更高滴度的抗OVA IgG2a,这表明这些疫苗具有更偏向Th1的免疫病理学特征。由于偏向Th2的疫苗会引发过敏反应,具有平衡Th1/Th2反应的mRNA疫苗更有利于转化应用于临床。总体而言,齐墩果酸可作为mRNA疫苗的佐剂,并有可能降低疫苗相关不良事件的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/4a0556525c0c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/fde2d9931601/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/dbd37e45f9f0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/1d9a903e5f0f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/3be5f3ac3636/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/12532e1447d6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/4a0556525c0c/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/fde2d9931601/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/dbd37e45f9f0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/1d9a903e5f0f/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/3be5f3ac3636/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/12532e1447d6/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/08e3/12169741/4a0556525c0c/gr5.jpg

相似文献

1
Exploring the potential of saponins as adjuvants in lipid-nanoparticle-based mRNA vaccines.探索皂苷作为基于脂质纳米颗粒的mRNA疫苗佐剂的潜力。
Mol Ther Methods Clin Dev. 2025 May 21;33(2):101495. doi: 10.1016/j.omtm.2025.101495. eCollection 2025 Jun 12.
2
Lipid nanoparticles as adjuvant of norovirus VLP vaccine augment cellular and humoral immune responses in a TLR9- and type I IFN-dependent pathway.脂质纳米颗粒作为诺如病毒VLP疫苗的佐剂,通过TLR9和I型干扰素依赖性途径增强细胞免疫和体液免疫反应。
J Virol. 2024 Dec 17;98(12):e0169924. doi: 10.1128/jvi.01699-24. Epub 2024 Nov 4.
3
Lipid nanoparticle composition for adjuvant formulation modulates disease after influenza virus infection in quadrivalent influenza vaccine vaccinated mice.用于佐剂配方的脂质纳米颗粒组合物调节四价流感疫苗接种小鼠流感病毒感染后的疾病。
Front Immunol. 2024 Apr 22;15:1370564. doi: 10.3389/fimmu.2024.1370564. eCollection 2024.
4
A Polysorbate-Based Lipid Nanoparticle Vaccine Formulation Induces In Vivo Immune Response Against SARS-CoV-2.一种基于聚山梨酯的脂质纳米颗粒疫苗制剂可诱导针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的体内免疫反应。
Pharmaceutics. 2025 Mar 29;17(4):441. doi: 10.3390/pharmaceutics17040441.
5
Lipid Nanoparticle with 1,2-Di-O-octadecenyl-3-trimethylammonium-propane as a Component Lipid Confers Potent Responses of Th1 Cells and Antibody against Vaccine Antigen.作为一种组成脂质的 1,2-二油烯基-3-三甲铵丙烷脂质纳米颗粒赋予了 Th1 细胞强烈的反应和针对疫苗抗原的抗体。
ACS Nano. 2024 Jul 2;18(26):16589-16609. doi: 10.1021/acsnano.4c00278. Epub 2024 Jun 17.
6
A novel lipid nanoparticle adjuvant significantly enhances B cell and T cell responses to sub-unit vaccine antigens.一种新型脂质纳米颗粒佐剂可显著增强B细胞和T细胞对亚单位疫苗抗原的反应。
Vaccine. 2016 Jan 2;34(1):110-9. doi: 10.1016/j.vaccine.2015.10.132. Epub 2015 Nov 10.
7
Lipid nanoparticle-based mRNA candidates elicit potent T cell responses.基于脂质纳米颗粒的信使核糖核酸候选物引发强烈的T细胞反应。
Biomater Sci. 2023 Jan 31;11(3):964-974. doi: 10.1039/d2bm01581a.
8
Time-Resolved Inspection of Ionizable Lipid-Facilitated Lipid Nanoparticle Disintegration and Cargo Release at an Early Endosomal Membrane Mimic.在早期内体膜类似物中对可离子化脂质促进的脂质纳米颗粒的崩解和载药释放进行时间分辨检测。
ACS Nano. 2024 Aug 27;18(34):22989-23000. doi: 10.1021/acsnano.4c04519. Epub 2024 Aug 12.
9
Deconvolution of cargo delivery and immunogenicity following intranasal delivery of mRNA lipid nanoparticle vaccines.鼻内递送mRNA脂质纳米颗粒疫苗后货物递送与免疫原性的去卷积分析
Mol Ther Nucleic Acids. 2025 Apr 24;36(2):102547. doi: 10.1016/j.omtn.2025.102547. eCollection 2025 Jun 10.
10
High-Throughput Screening Identifies Differential Influences on mRNA Lipid Nanoparticle Immune Cell Delivery by Administration Route.高通量筛选鉴定给药途径对 mRNA 脂质纳米颗粒免疫细胞递送的差异影响。
ACS Nano. 2024 Jun 25;18(25):16151-16165. doi: 10.1021/acsnano.4c01171. Epub 2024 Jun 11.

引用本文的文献

1
The Elicitation of an Antigen-Specific Antibody Immune Response Using a Nanoparticulate Adjuvant Derived from .使用源自……的纳米颗粒佐剂引发抗原特异性抗体免疫反应
Molecules. 2025 Aug 9;30(16):3328. doi: 10.3390/molecules30163328.

本文引用的文献

1
Complete biosynthesis of the potent vaccine adjuvant QS-21.QS-21 强效疫苗佐剂的全生物合成。
Nat Chem Biol. 2024 Apr;20(4):493-502. doi: 10.1038/s41589-023-01538-5. Epub 2024 Jan 26.
2
From Bench to Bedside: Implications of Lipid Nanoparticle Carrier Reactogenicity for Advancing Nucleic Acid Therapeutics.从 bench 到 bedside:脂质纳米颗粒载体反应原性对推进核酸治疗的影响 。 (注:bench 和 bedside 在这里可能是特定语境下的术语,比如 bench 可能表示实验室研究阶段,bedside 表示临床应用阶段,可根据具体背景进一步准确理解,这里按字面翻译)
Pharmaceuticals (Basel). 2023 Jul 31;16(8):1088. doi: 10.3390/ph16081088.
3
Cholesterol modulates the physiological response to nanoparticles by changing the composition of protein corona.
胆固醇通过改变蛋白质冠的组成来调节对纳米颗粒的生理反应。
Nat Nanotechnol. 2023 Sep;18(9):1067-1077. doi: 10.1038/s41565-023-01455-7. Epub 2023 Aug 3.
4
Leveraging Biological Buffers for Efficient Messenger RNA Delivery via Lipid Nanoparticles.利用生物缓冲液通过脂质纳米粒高效传递信使 RNA。
Mol Pharm. 2022 Nov 7;19(11):4275-4285. doi: 10.1021/acs.molpharmaceut.2c00587. Epub 2022 Sep 21.
5
Bifurcation of signalling in human innate immune pathways to NF-kB and IRF family activation.人类先天免疫途径中 NF-κB 和 IRF 家族激活的信号转导分支。
Biochem Pharmacol. 2022 Nov;205:115246. doi: 10.1016/j.bcp.2022.115246. Epub 2022 Sep 8.
6
Ionizable Lipid Nanoparticles Enhanced the Synergistic Adjuvant Effect of CpG ODNs and QS21 in a Varicella Zoster Virus Glycoprotein E Subunit Vaccine.可电离脂质纳米颗粒增强了水痘带状疱疹病毒糖蛋白E亚单位疫苗中CpG ODNs和QS21的协同佐剂作用。
Pharmaceutics. 2022 Apr 30;14(5):973. doi: 10.3390/pharmaceutics14050973.
7
Lipid nanoparticles enhance the efficacy of mRNA and protein subunit vaccines by inducing robust T follicular helper cell and humoral responses.脂质纳米颗粒通过诱导强烈的滤泡辅助性 T 细胞和体液反应来提高 mRNA 和蛋白亚单位疫苗的效力。
Immunity. 2021 Dec 14;54(12):2877-2892.e7. doi: 10.1016/j.immuni.2021.11.001. Epub 2021 Nov 4.
8
Extracellular vesicles as a next-generation drug delivery platform.细胞外囊泡作为下一代药物递送平台。
Nat Nanotechnol. 2021 Jul;16(7):748-759. doi: 10.1038/s41565-021-00931-2. Epub 2021 Jul 1.
9
A high-throughput Galectin-9 imaging assay for quantifying nanoparticle uptake, endosomal escape and functional RNA delivery.一种高通量 Galectin-9 成像分析方法,用于定量检测纳米颗粒摄取、内涵体逃逸和功能性 RNA 递呈。
Commun Biol. 2021 Feb 16;4(1):211. doi: 10.1038/s42003-021-01728-8.
10
Illuminating endosomal escape of polymorphic lipid nanoparticles that boost mRNA delivery.阐明多形态脂质纳米粒的内涵体逃逸机制,该纳米粒可促进 mRNA 递送。
Biomater Sci. 2021 Jun 15;9(12):4289-4300. doi: 10.1039/d0bm01947j.